| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2136be309d6c44157ddbe6d7ee2defc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b441828c8d1195041176021712f4e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e16e2f1c1892a4c47e81e26f1327294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0b71b03375bde3005e427d15add2f3e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2334-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-926 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2000-03-17^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ec3909466235000b8a699ff83ed6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5ea762fb839df6340fb568e8742c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90213dd06aba2ad0037746aea87c1e4d |
| publicationDate |
2000-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0055354-A2 |
| titleOfInvention |
A diagnostic test |
| abstract |
There is provided a method for the detection of a disease comprising the following steps: (i) obtaining a biological sample from a human subject; (ii) applying the biological sample to a sialidase substrate which has been immobilised on a solid support medium; and (iii) detecting a change in the immobilised sialidase substrate. The substrate is preferably 5-bromo-4-chloro-3-indoyl α-D-N-acetyl neuraminic acid or a salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008018074-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003047497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7591978-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02065122-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704702-B2 |
| priorityDate |
1999-03-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |